China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use
New protein-based vaccine to be used as booster jab, local media reports.
Abone Ol
China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.
Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.
Most Read News
-
Tens of thousands of homes without power as severe
-
Pakistan's capital locked down ahead of opposition
-
Philippines heightens president’s security after vice
-
Ukraine claims it downed 50 Russian drones in overnight
-
ICC arrest warrant against Israel's Netanyahu 'glimmer
-
'No pathway,' Australian government abandons proposed
-
Gaza death toll tops 44,200 as Israeli attacks kill 35
-
UK, France, Germany, US welcome UN nuclear watchdog’s
-
UK seeking new EU negotiator as premier aims to reset
-
Modi's BJP, allies set to retain power in India's
